Table 5 –
Analyse of baseline patient characteristics and modeling parameters.
| Variable | Control | PAD | Total | P-Value |
|---|---|---|---|---|
| kt | 2.47 (2.10, 2.85) | 4.72 (3.33, 5.56) | 3.59 (2.39, 4.74) | 0.003 |
| Ktissue | 1.81 (1.81, 1.81) | 3.68 (3.18, 4.41) | 2.75 (1.81, 3.49) | 0.001 |
| φ | 0.61 (0.58, 0.64) | 0.52 (0.49, 0.54) | 0.5663 (0.508, 0.63) | 0.016 |
| OFC | 15.03 (11.96, 18.02) | 13.17 (9.07, 12.46) | 14.1 (9.79, 17.49) | 0.08 |
| pυ | 48.59 (47.76, 50.31) | 52.02 (49.48, 56.48) | 50.31 (47.85, 53.51) | 0.06 |
All values are medians and interquartile range (IQR). P-values were calculated with the Kruskal-Wallis rank test. Control group: n=10; PAD group: n=10.